Urticaria and Angioedema in Pregnancy

Current Dermatology Reports

Volumn 2, Issue 4, 2013, Pages 236-242

  Kadar, Laliv ^a   Kivity, Shmuel ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Angioedema; C1 esterase inhibitor; Estrogen; Pemphigoid gestationis; Pregnancy; Progesterone; Pruritic urticarial papules and plaques of pregnancy; Urticaria

Indexed keywords

ANTIHISTAMINIC AGENT; BLOOD CLOTTING FACTOR 12; BRADYKININ; BRADYKININ B2 RECEPTOR; COMPLEMENT COMPONENT C1S INHIBITOR; ESTRIOL; ESTROGEN; HIGH MOLECULAR WEIGHT KININOGEN; IMMUNOGLOBULIN G1; KALLIKREIN; PREKALLIKREIN; PROGESTERONE; STEROID; TAMOXIFEN;

ANGIONEUROTIC EDEMA; AUTOIMMUNE DISEASE; DERMATITIS; DESENSITIZATION; DISEASE EXACERBATION; ENDOCRINE DISEASE; FEMALE; FIBRINOLYSIS; HORMONAL REGULATION; HUMAN; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE TEST; LARYNX EDEMA; PEMPHIGOID GESTATIONIS; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROGESTERONE URTICARIA; PRURITUS; RASH; REVIEW; URTICARIA;

EID: 84930455933     PISSN: None     EISSN: 21624933     Source Type: Journal    
DOI: 10.1007/s13671-013-0061-y     Document Type: Review

References (67)

1. Kaplan AP. In: Adkinson Jr NF, Busse WW, Bochner BS, et al., editors. Middleton's allergy: principles and practice. 7th ed. Philadelphia: Elsevier; 2009. p. 1064-7.
2. Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105(4): 664.
3. Carr TF, Saltoun CA. Chapter 21: urticaria and angioedema. Allergy Asthma Proc. 2012;33 Suppl 1: S70-2.
4. Saltoun CA. Urticaria, angioedema and hereditary angioedema. In: Grammer LC, Greenberger PA, editors. Patterson's allergic diseases. 7th ed. Philadelphia: Lippincott Williams and Wilkins; 2009. p. 539-53.
5. Burton GJ, Sibly CP, Jauniaux E. Placental anatomy and physiology. In: Gabbe SG, Niebyl JR, Galan HL, et al., editors. Obstetrics: normal and problem pregnancies. 6th ed. Philadelphia: Elsevier; 2012. p. 17-9.
6. Cunningham FG, Leveno KL, Bloom SL, et al. Implantation, embryogenesis, and placental development. In: Williams obstetrics, 23rd edn. New York: McGraw-Hill; 2010.
7. Matsuzaki J, Tsuji T, Imazeki I, et al. Immunosteroid as a regulator for Th1/Th2 balance: its possible role in autoimmune diseases. Autoimmunity. 2005;38(5): 369-75.
8. Hughes GC, Clark EA. Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity. 2007;40: 470-81.
9. Sakiani S, Olsen NJ, Kovacs WJ. Gonadal steroids and humoral immunity. Nat Rev Endocrinol. 2013;9(1): 56-62.
10. Incorvaia E, Sicouri L, Petersen-Mahrt SK, Schmitz KM. Hormones and AID: balancing immunity and autoimmunity. Autoimmunity. 2013;46(2): 128-37.
11. Hamano N, Terada N, Maesako K, Numata T, Konno A. Effect of sex hormones on eosinophilic inflammation in nasal mucosa. Allergy Asthma Proc. 1998;19: 263-9.
12. Zierau O, Zenclussen AC, Jensen F. Role of female sex hormones, estradiol and progesterone, in mast cell behavior. Front Immunol. 2012;3: 169.
13. Tanriverdi F, Silveira LF, MacColl GS, Bouloux PM. The hypothalamic-pituitary gonadal axis: immune function and autoimmunity. J Endocrinol. 2003;176(3): 293-304.
14. Chen W, Mempel M, Schober W, et al. Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy. 2008;63(11): 1418-27.
15. Robinson DP, Klein SL. Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav. 2012;62(3): 263-71.
16. Tedeschi SK, Bermas B, Costenbader KH. Sexual disparities in the incidence and course of SLE and RA. Autoimmunity. 2012;45(5): 364-76.
17. Cutolo M, Sulli A, Capellino S, et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus. 2004;13(9): 635-8.
18. Xiong YH, Yuan Z, He L. Effects of estrogen on CD4(+) CD25(+) regulatory T cell in peripheral blood during pregnancy. Asian Pac J Trop Med. 2013;6(9): 748-52.
19. Zaitsu M, Narita S, Lambert KC, et al. Estradiol activates mast cells via an ongenomic estrogen receptor-alpha and calcium influx. Mol Immunol. 2007;44: 1977-85.
20. Narita S, Goldblum RM, Watson CS, et al. Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators. Environ Health Perspect. 2007;115: 48-52.
21. Vasconcelos C, Xavier P, Vieira AP, et al. Autoimmune progesterone urticaria. Gynecol Endocrinol. 2000;14(4): 245-7.
22. Roth MM. Pregnancy dermatoses: diagnosis, management, and controversies. Am J Clin Dermatol. 2011;12(1): 25-41.
23. Toms-Whittle LM, John LH, Griffiths DJ, Buckley DA. Autoimmune progesterone dermatitis: a diagnosis easily missed. Clin Exp Dermatol. 2011;36(4): 378-80.
24. Bandino JP, Thoppil J, Kennedy JS, Hivnor CM. Iatrogenic autoimmune progesterone dermatitis caused by 17alpha-hydroxyprogesterone caproate for preterm labor prevention. Cutis. 2011;88(5): 241-3.
25. O'Rourke J, Khawaja N, Loughrey J, McKenna P. Autoimmune progesterone dermatitis in a parturient for emergency caesarean section. Int J Obstet Anesth. 2004;13(4): 275-8.
26. Prieto-Garcia A, Sloane DE, Gargiulo AR, et al. Autoimmune progesterone dermatitis: clinical presentation and management with progesterone desensitization for successful in vitro fertilization. Fertil Steril. 2011;95(3): 1121.
27. Kasperska-Zajac A, Brzoza Z, Rogala B. Sex hormones and urticaria. J Dermatol Sci. 2008;52(2): 79-86. An excellent article that reviews the current interaction of estrogen and progesterone with urticaria in women.
28. Yotsumoto S, Shimomai K, Hashiguchi T, et al. Estrogen dermatitis: a dendritic-cell-mediated allergic condition. Dermatology. 2003;207(3): 265-8.
29. Zauli D, Deleonardi G, Foderaro S, et al. Thyroid autoimmunity in chronic urticaria. Allergy Asthma Proc. 2001;22(2): 93-5.
30. Hide M, Francis DM, Grattan CEH, et al. Autoantibodies against the high affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328: 1599-604.
31. Asero R. Sex differences in the pathogenesis of chronic urticaria. J Allergy Clin Immunol. 2003;111(2): 425-6.
32. Kasperska-Zajac A, Brzoza Z, Rogala B. Lower serum concentration of dehydroepiandrosterone sulphate in patients suffering from chronic idiopathic urticaria. Allergy. 2006;61(12): 1489-90.
33. Cicardi M, Agostoni A. Hereditary angioedema. N Engl J Med. 1996;334: 1666.
34. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore). 1992;71: 206-15.
35. Georgy MS, Pongracic JA. Chapter 22: hereditary and acquired angioedema. Allergy Asthma Proc. 2012;33 Suppl 1: S73-6.
36. Agostoni A, Aygören-Pürsün E, Binkley KE, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004;114(3 Suppl): S51-S131. General review on HAE: diagnosis, pathogenesis and treatment in different populations including pregnant women.
37. Agostoni A, Aygoren-Pursun E, Binkley KE, et al. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med. 2003;163: 1229-35.
38. Zilberberg MD, Nathanson BH, Jacobsen T, Tillotson G. Descriptive epidemiology of hereditary angioedema hospitalizations in the United States, 2004-2007. Allergy Asthma Proc. 2011;32(3): 248-54.
39. Geng B, Riedl MA. HAE update: special considerations in the female patient with hereditary angioedema. Allergy Asthma Proc. 2013;34(1): 13-8.
40. Visy B, Füst G, Varga L, et al. Sex hormones in hereditary angioneurotic oedema. Clin Endocrinol (Oxf). 2004;60(4): 508-15.
41. Bouillet L, Longhurst H, Boccon-Gibod I, et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol. 2008;199(5): 484. Although a retrospective study, it is a part of the PREHAEAT Project on 150 type I HAE women that speculates different phenotypes of hormonal sensitivity in women patients.
42. Caballero T, Farkas H, Bouillet L, C-1-INH Deficiency Working Group, et al. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. J Allergy Clin Immunol. 2012;129(2): 308-20. Evidence based guidelines for the management of HAE in pregnancy and the peripartum period.
43. Chinniah N, Katelaris CH. Hereditary angioedema and pregnancy. Aust N Z J Obstet Gynaecol. 2009;49(1): 2-5.
44. Martinez-Saguer I, Rusicke E, Aygören-Pürsün E, et al. Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate. Am J Obstet Gynecol. 2010;203(2): 131e1-7. A prospective study important for describing risk factors for increased attack rate in HAE patients during pregnancy.
45. Czaller I, Visy B, Csuka D, et al. The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey. Eur J Obstet Gynecol Reprod Biol. 2010;152(1): 44-9. A prospective study that emphasizes the safety of C1 esterase inhibitor treatment in 91 cases during pregnancy.
46. Cunningham DS, Jensen JT. Hereditary angioneurotic edema in the puerperium. A case report. J Reprod Med. 1991;36(4): 312-3.
47. Cox M, Holdcroft A. Hereditary angioneurotic oedema: current management in pregnancy. Anaesthesia. 1995;50: 534-49.
48. Bouillet L, Longhurst H, Boccon-Gibod I, et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol. 2008;199(5): 484. e1-4.
49. Nielsen EW, Gran JT, Straume B, et al. Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses. J Intern Med. 1996;239(2): 119-30.
50. Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet. 2000;356(9225): 213-7.
51. Zuraw BL, Bork K, Binkley KE, et al. Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc. 2012;33 Suppl 1: S145-56. A recently published internal panel consensus defining the diagnostic criteria, clinical characteristics, diagnosis and possible treatment for type III HAE.
52. Bork K, Gül D, Hardt J, Dewald G. Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course. Am J Med. 2007;120(11): 987-92.
53. Bork K, Wulff K, Meinke P, et al. A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor. Clin Immunol. 2011;141(1): 31-5.
54. Binkley KE, Davis 3rd A. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol. 2000;106(3): 546-50.
55. Vitrat-Hincky V, Gompel A, Dumestre-Perard C, et al. Type III hereditary angio-oedema: clinical and biological features in a French cohort. Allergy. 2010;65(10): 1331-6.
56. Bork K, Fischer B, Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med. 2003;114(4): 294-8.
57. Bork K, Wulff K, Hardt J, et al. Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. J Allergy Clin Immunol. 2009;124(1): 129-34. An excellent review of the leading group that described first and investigates patients with HAE type III.
58. Picone O, Donnadieu AC, Brivet FG, et al. Obstetrical complications and outcome in two families with hereditary angioedema due to mutation in the F12 gene. Obstet Gynecol Int. 2010;2010: 957507.
59. Bowen T, Cicardi M, Farkas H, et al. 2010 international consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010;6(1): 24. Canadian consensus algorithm that presents flowcharts for the diagnosis and treatment of acute attacks and preventive treatment of all 3 types of HAE.
60. Matz H, Orion E, Wolf R. Pruritic urticarial papules and plaques of pregnancy: polymorphic eruption of pregnancy (PUPPP). Clin Dermatol. 2006;24(2): 105-8.
61. Trattner A, Ingber A, Sandbank M. Antiepidermal cell surface antibodies in a patient with pruritic urticarial papules and plaques of pregnancy. J Am Acad Dermatol. 1991;24(2 Pt 1): 306-8.
62. Yancey KP, Hall RP, Lawley TJ. Pruritic urticarial papules and plaques of pregnancy. Clinical experience in twenty-five patients. J Am Acad Dermatol. 1984;10: 473-80.
63. Cohen LM, Capeless EL, Krusinski PA, et al. Pruritic urticarial papules and plaques of pregnancy and its relationship to maternal-fetal weight gain and twin pregnancy. Arch Dermatol. 1989;125: 1534-6.
64. Im S, Lee E-S, Kim W, et al. Expression of progesterone receptor in human keratinocytes. J Korean Med Sci. 2000;15: 647-54.
65. Zillikens D. Pemphigoid gestationis: immunological aspects. J Eur Acad Dermatol Venereol. 2004;18 Suppl 2: 6-42.
66. Schirren H, Messer G, Schirren CG, Meurer M. Immunogenetic findings in herpes gestationis. Hautarzt. 1993;44(12): 767-71.
67. Jenkins RE, Shornick J. Pemphigoid gestationis. In: Black MM, Ambros-Rudolph C, Edwards L, et al., editors. Obstetric and gynecologic dermatology. 3rd ed. London: Mosby; 2008. p. 37-47.